Pharmaceutical products | Tenderlake

Pharmaceutical products

Contract Value:
PLN 4M - 4M
Notice Type:
Contract Notice
Published Date:
29 January 2024
Closing Date:
28 February 2024
Location(s):
PL514 Miasto Wrocław (PL Poland/POLSKA)
Description:
Procurement for the supply of various pharmaceutical products used in drug programmes, including interferon solutions, tofacitinib tablets, infliximab powder, entecavir tablets, botulinum toxin injections, adalimumab solution, cladribinum tablets, siponimod tablets, palivizumab solution, tenofovir disoproxil tablets, and sofosbuvir+velpatasvir+voxilaprevir tablets.
PN 07/24 SUPPLY OF MEDICINES USED IN DRUG PROGRAMMES

The subject of the contract is the SUPPLY OF MEDICINES USED IN DRUG PROGRAMMES – in accordance with Appendix 1 to the Terms of Reference.

1.Detailed description of the product, required form, dose, volume, quantity per pack, unit of measurement, quantity op. defines the ASSORTMENT AND PRICE FORM, constituting Annex 1 to the SWZ.

2. Detailed conditions and rules for the implementation of the subject of the contract are additionally specified

Contractual Terms and Conditions constituting Appendix No. 4 to the Terms of Use "Contractual Terms".

3. Delivery date - according to current needs, each time within a maximum of 2 days

working from the date of placing the order.

Task No. 1

Interferon beta-1a solution for injection in a 30mcg/0.5ml pen 4 pens (+4 injection needles + 4 pen guards) pack of 55

Task No. 10

Tofacitinib tabl. powl. 5 mg op. cit. 56 tabl. 70

Task No. 11

Tofacitinib tabl. powl. 10 mg op. cit. 56 tabl. 10

Task No. 12

Infliximab powder for concentrate for solution for infusion 100mg pack 1 vial of 2000

Task No. 13

Entecavir tabl.powl. 0,5 mg op. 30 tabl. 5000

Task No. 14

Ofatumumab solution for injection in a 20mg pen pack 1 pen 0.4 ml 120

Task No. 15

Ponesimod Film-coated tablets 20mg pack 28 tabl. 50

Task No. 16

Botulinum toxin type A for injection. Medicinal product used in the drug program for the treatment of spasticity of the upper and lower limbs after stroke and in the drug program for the prophylactic treatment of patients with chronic migraine powder for solution for injection 100 units. 1 vial of 300

Task No. 17

Botulinum toxin type A, free of complexing proteins powder for solution for injection 100 units. 1 vial of 50

Task No. 18

Botulinum toxin type A for injection powder for solution for injection 300 units, op. cit. 1 vial of 50

Powder for solution for injection 500U, pack 1 vial of 50

Task No. 2

Inteferon beta-1b, 0.3 mg (9.6 IU IU) powder for recombinant interferon beta-1b for solution for 0.25 mg/ml. powder and solvent for solution for injection 250 mcg/ml 15 vials of powder and 15 amp.-teat. with dissolver op. cit. 110

Exercise NR 3

Adalimumab solution for injection in pre-filled syringe 40 mg/0.8 ml pack 2 amp.-teat. Op. 200

Task No. 4

Cladribinum tabl. 10mg op. 1 szt. 20 ,

Cladribinum tabl. 10mg op. 4 szt. 30.

Task No. 5

Siponimod Film-coated tablets 0.25 mg pack 12 tabl. 30

Siponimod Film-coated tablets 0.25 mg pack 120 tabl. 20

Siponimod 2 mg 28 tabl. 60

Task No. 6

Inteferon beta-1a solution for injection 44mcg/0.5ml 4 cartridges op. 50

Task No. 7

Palivizumab solution for injection 0.05g/0.5ml pack 1 vial of 140,

Palivizumab solution for injection 0.1 g/ml pack 1 vial of 120.

Task No. 8

Tenofovir disoproxil tabl.powl. 245mg up. 30 tabl. 3500

Task No. 9

Sofosbuvir+Velpatasvir+Voxilaprevir tabl. powl. 400mg + 100mg + 100mg op. 28 tabl. 25

Download full details as .pdf
The Buyer:
Wojewódzki Szpital Specjalistyczny im. J. Gromkowskiego
CPV Code(s):
33600000 - Pharmaceutical products